Your Health Questions
Answered by Professionals

Angioedema and chronic hives often coexist, sharing mast cell–driven swelling and itch but differing in depth of skin involvement, underlying pathways, and treatment tiers. Management can range from second-generation antihistamines to omalizumab or bradykinin targeted agents based on your specific triggers and symptoms. There are several factors to consider: see below for complete details on pathophysiology, diagnostic steps, management strategies, emergency red flags, and personalized next steps in your healthcare journey.

Recognizing angioedema warning signs in chronic urticaria like rapid swelling of the lips, tongue or throat is vital to prevent airway obstruction and ensure timely treatment with antihistamines, corticosteroids and epinephrine. A stepwise doctor’s approach including detailed history, physical exam, lab tests, risk assessment and tailored management helps guide care, while patient education on triggers, medication adherence and emergency response is essential. There are many important details to consider; see below for the complete answer.

Chronic hives in an autoimmune subtype arise from anti-FcεRI IgG autoantibodies that cross-link high-affinity IgE receptors on mast cells and basophils, driving persistent histamine release and affecting about 30 to 40 percent of patients with chronic spontaneous urticaria. Recognizing this mechanism is crucial, as it guides the use of targeted treatments such as high-dose H1 antihistamines, omalizumab, and immunosuppressants when standard therapy fails. Multiple factors—from advanced diagnostic tests (ASST, BAT, immunoassays) to lifestyle adjustments—can impact your next steps in care, so see below for more important details that could influence your management plan.

Anti-IL-4 receptor monoclonal antibodies, such as dupilumab, block the IL-4/IL-13 pathway to reduce airway inflammation, asthma exacerbations, and steroid dependence in moderate-to-severe allergic asthma. Approved for patients with Type 2 inflammatory markers who remain uncontrolled on standard inhalers, this precision biologic requires subcutaneous injections, side effect monitoring, and insurance planning. There are many factors to consider—including eligibility criteria, dosing schedules, potential side effects, monitoring protocols, and cost support—so see below for complete details to guide your next steps with your healthcare provider.

Anti-IL-5 therapies for lung health target the cytokine IL-5 or its receptor to reduce eosinophilic inflammation in conditions like eosinophilic asthma, resulting in fewer exacerbations, lower oral steroid use, and improved lung function. However, many important details on patient selection, dosing schedules, monitoring plans, potential side effects, and how to combine these treatments with other asthma medications could affect which next steps you take in your care. See below for the complete information that could guide your decisions.

Turmeric, ginger, licorice root, and other anti-inflammatory herbs may support lung health by reducing airway inflammation and protecting tissue but can interact with medications, alter blood pressure, or trigger allergic reactions. There are several factors to consider including proper dosing, potential side effects, and knowing when to seek medical attention. See below for complete safety warnings and usage guidelines that could impact your next steps.

Antihistamine-resistant hives occur when up to four times the standard dose of second-generation H1 blockers fails to control itching welts driven by autoimmune processes, thyroid autoimmunity, infections, physical triggers or stress. Specialist next steps include a detailed history, basic and specialized tests, and add-on therapies such as omalizumab, immunosuppressants or leukotriene antagonists alongside lifestyle and trigger management. See below for a comprehensive overview of underlying causes, diagnostic approaches and personalized treatment strategies to guide your healthcare journey.

Aspirin exacerbated respiratory disease is a chronic condition characterized by the triad of asthma, chronic rhinosinusitis with nasal polyps, and sensitivity to aspirin or other NSAIDs that can rapidly trigger wheezing, congestion, and gastrointestinal distress. Doctors diagnose AERD through a detailed medical history, pulmonary function tests, nasal endoscopy or imaging, and supervised aspirin or NSAID challenge in specialized centers. Management includes avoiding COX-1 inhibiting medications, using leukotriene modifiers, corticosteroids, aspirin desensitization, biologic therapies, possible sinus surgery, and supportive measures; see below for crucial details that may influence your next steps in care.

Asthma mortality is low globally (about 0.44 deaths per 100,000 people annually) but still accounts for roughly 9–10 deaths per day in the US, with higher risks in young children, older adults, and Black and Hispanic populations. Evidence-backed prevention metrics—such as tracking symptom frequency, rescue inhaler use, peak expiratory flow readings, and maintaining ≥80% medication adherence—combined with personalized action plans and trigger control can greatly reduce severe attacks. There are several factors to consider when applying these prevention strategies and understanding your individual risk profile; see below for a comprehensive breakdown of statistics, measurable metrics, and practical next steps to guide your healthcare decisions.

Asthma-COPD overlap syndrome features mixed asthma-like reversibility and COPD-like persistent airflow limitation and requires a thorough workup that includes detailed medical history, spirometry with reversibility testing, imaging, and laboratory analyses. There are several important details to consider when interpreting test results, planning combination therapies, and monitoring exacerbations. See below for the full diagnostic steps and next healthcare actions.

Baker’s asthma and wheat allergy both result from immune reactions to wheat proteins but differ in exposure routes, affected organs, and diagnostic tests. Baker’s asthma arises from inhaling flour dust and is evaluated with spirometry, peak flow monitoring, and specific inhalation challenges, while wheat allergy follows ingestion and relies on skin prick testing, serum IgE measurements, and oral food challenges. Several factors influence the choice of tests, management strategies, and urgency of care based on your history and symptom patterns; see complete guidelines below for detailed diagnostic steps, treatment options, and when to seek further help.

Basophil counts in chronic hives can indicate disease activity, with low basophil levels often linked to more severe or antihistamine-resistant urticaria and fluctuations paralleling flares. However, basophil numbers are influenced by timing, medications, and other lab markers and are best used alongside symptom tracking and clinical assessment. For a full understanding of basophil biology, measurement ranges, clinical evidence, treatment implications, and patient tips, see below.

Distinguishing bed bug bites from chronic hives relies on differences in rash patterns, timing, lesion duration, blanching, and itch sensation, along with clues like clustered bites versus rapidly changing welts and response to antihistamines. Key signs such as nighttime itching, visible insects, or angioedema also guide accurate diagnosis. There are several factors to consider that could affect which next steps you take in your healthcare journey, so see below for more important details to ensure a correct diagnosis and targeted treatment.

Biologic injections for severe asthma are tailored based on your asthma phenotype, biomarker levels and treatment response, with common schedules ranging from every two to eight weeks to maximize symptom control and minimize flare ups. Working with your healthcare team to review your blood test results, past treatment history and insurance coverage will help you choose the right therapy and dosing interval. There are several factors to consider such as interval adjustments, missed dose management and monitoring requirements, so see below for complete details that could impact your next steps.

Researchers are exploring a range of targeted biological therapies, including anti-IgE antibodies, cytokine blockers, BTK inhibitors and CAR T methods, to prevent or blunt life-threatening anaphylaxis. There are several factors to consider about efficacy, safety and patient selection. See below for full details on these emerging treatments and other important considerations that could impact your next steps in care.

Biologics such as omalizumab target IgE and inflammatory cytokines to calm the overactive immune response that drives chronic spontaneous urticaria. This precision approach can reduce welts and itching and often allows patients to taper off high-dose antihistamines and steroids when standard therapies are insufficient. There are several important considerations including candidacy criteria, dosing schedules, efficacy timelines and safety monitoring that could affect your next steps in care; see below for complete details.

Targeted biologics block key immune mediators IgE, IL-5 or IL-4/IL-13 to significantly reduce airway inflammation, decrease severe asthma flare-ups by up to 60% and improve lung function in patients whose allergic asthma remains uncontrolled on high-dose inhaled steroids. These precision therapies also allow tapering of oral steroids and generally have a favorable safety profile with monitoring for rare allergic reactions. There are several factors to consider, including T2 inflammation markers, candidate selection and administration schedules, so see complete details below.

Blood eosinophil counts offer insight into airway inflammation and help identify eosinophilic asthma subtypes that often respond best to inhaled corticosteroids or targeted biologics using thresholds of <150, 150–300, and >300 cells/µL. Clinicians also monitor trends over time to predict treatment response and adjust management. Several factors can influence counts—from allergies and medications to infections and seasonal changes—and there are important details to consider, so see below for complete information that could impact your next steps in care.

Blood tests for food allergies measure specific immunoglobulin E levels but vary in sensitivity (around 70 to 95 percent) and specificity (50 to 85 percent), so they can yield false positives or false negatives depending on lab methods and threshold cut-offs. Multiple factors such as cross-reactivity, individual immune differences, and testing technology influence accuracy. Accurate diagnosis requires interpreting test results alongside your clinical history and other diagnostics such as skin prick tests or oral food challenges; see below for complete details on these factors and next steps in your care.

Bronchial thermoplasty is an FDA-approved, non-drug procedure for adults with severe persistent asthma that remains uncontrolled on maximal inhaled therapy and has been shown in trials to reduce severe exacerbations by up to 50% long term and cut emergency visits by more than 80% in the first year. Patients also report improved quality of life and modest lung function gains, but success depends on careful patient selection, operator experience, and diligent follow-up care. There are several factors and potential early side effects to consider, so see below to delve into all the important details before deciding on your next steps.

Bronchiectasis and severe refractory asthma can both cause persistent cough, wheezing and breathlessness but stem from different airway changes, diagnostic findings and treatment needs. Bronchiectasis involves permanent bronchi dilation, mucus buildup and recurrent infections whereas severe refractory asthma features reversible airway narrowing and inflammation that resists standard therapies. See below for key differences in imaging results, sputum and biomarker analysis, management strategies and warning signs that could guide your next healthcare steps.

CBD oil offers potential anti-inflammatory and neuromodulatory benefits that may help relieve severe chronic skin itch, with small trials in eczema and psoriasis showing modest improvements but lacking large scale confirmation. There are many factors to consider before using CBD oil such as product purity, dosing, interactions, and safety monitoring; see below for critical details on trial evidence, practical usage tips, and when to seek medical advice.

Both celiac disease and wheat allergy can trigger itchy skin reactions after eating wheat, but celiac’s dermatitis herpetiformis appears 24 to 48 hours later as symmetrical, blistering clusters requiring a strict gluten-free diet, while wheat allergy causes rapid-onset hives or angioedema within minutes to two hours and often responds to antihistamines or epinephrine. Accurate diagnosis depends on factors like timing of symptoms, rash pattern, digestive or systemic signs, and tests such as skin biopsy for dermatitis herpetiformis or IgE testing for allergy. There are several important factors to consider in choosing your next healthcare steps; see below for complete details.

Chronic bronchitis and persistent allergic asthma both trigger coughing, wheezing and breathlessness but have distinct causes, inflammation types and treatment responses. Chronic bronchitis results from long-term irritant exposure leading to a productive cough and largely irreversible airflow limitation, while allergic asthma is driven by immune reactions to allergens and typically improves with inhaled steroids. See below for a detailed comparison of symptoms, diagnosis, management strategies and important considerations for when to seek medical care.

Chronic hives lasting over six weeks are red, itchy welts caused by persistent mast cell histamine release triggered by factors like autoimmunity, physical stimuli, infections, medications, or stress. Affecting about 1% of people, they can recur daily and significantly disrupt quality of life. There are several factors to consider for diagnosis, stepwise treatment, and self-care strategies—see below for important details that can help guide your next steps.

Chronic hives standard of care follows a step by step algorithm starting with a thorough evaluation, first line treatment with standard doses of non sedating H1 antihistamines, then dose escalation with additional antihistamines or H2 blockers, and finally biologics or immunosuppressants for resistant cases. This approach aims to control symptoms, minimize side effects, and identify any underlying triggers or conditions. There are several factors to consider including lifestyle measures, follow up intervals, and rare complications, so see below for complete information and important details to guide your next steps.

Chronic idiopathic urticaria causes daily or almost daily hives and sometimes deep tissue swelling lasting six weeks or more without a clear trigger, often disrupting sleep, work, or social life. Management focuses on blocking histamine and immune mediators with daily second generation antihistamines, add on therapies such as anti IgE antibodies, and supportive measures like cool compresses and stress reduction. See complete details on the biological pathways, common triggers, diagnostic steps, and full treatment strategies below.

Chronic respiratory fatigue stems from low oxygen delivery to tissues, causing persistent tiredness, shortness of breath and reduced stamina that go beyond ordinary fatigue. There are several factors to consider, from impaired ATP generation and lactic acid buildup to increased cardiac strain and brain fog; see below for the complete science, symptom checklist and guidance on evaluation and management.

Chronic skin welts that persist beyond six weeks often indicate chronic urticaria, marked by intensely itchy, red or skin-colored bumps that can merge or migrate and may involve deeper swelling known as angioedema. Underlying causes range from autoimmune reactions and physical triggers to idiopathic factors, and management can include daily antihistamines, trigger avoidance, and advanced prescription or biologic therapies. There are several factors to consider regarding duration, warning signs, and treatment options. See below for more details to guide your next steps in care.

Cinqair IV infusion (reslizumab) is a targeted biologic add-on therapy for adults with severe eosinophilic asthma that remains uncontrolled on high-dose inhaled corticosteroids plus another controller. It requires precise patient selection, weight-based dosing over 20 to 50 minutes, and vigilant monitoring for infusion reactions and long-term safety. See below for complete guidelines on pre-infusion assessments, dosing protocols, vital-sign monitoring, emergency measures, adverse-event management, and specialist referral criteria to inform your next steps.